Literature DB >> 20121358

Erosion of the spinous process: a potential cause of interspinous process spacer failure.

Jimmy D Miller1, Mary C Miller, Marsha G Lucas.   

Abstract

Interspinous process spacers have recently become available for treatment of symptomatic lumbar spinal stenosis. To date, there have been few data regarding the causes of failure. The authors present 2 cases in which there was erosion of the spinous processes adjacent to the interspinous process spacers. In 1 patient, the recurrence of symptoms was likely related to the erosive changes. Such abnormal changes allow settling of the posterior spinal elements and probably results from continued motion at the treated levels.

Entities:  

Mesh:

Year:  2010        PMID: 20121358     DOI: 10.3171/2009.9.SPINE09144

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  4 in total

1.  Posterior Arch Augmentation (Spinoplasty) before and after Single and Double Interspinous Spacer Introduction at the Same Level: Preventing and Treating the Failure?

Authors:  Luigi Manfré
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

2.  Computed tomography measurements of the lumbar spinous processes and interspinous space.

Authors:  Rolf Sobottke; Timmo Koy; Marc Röllinghoff; Jan Siewe; Thomas Kreitz; Daniel Müller; Christopher Bangard; Peer Eysel
Journal:  Surg Radiol Anat       Date:  2010-06-15       Impact factor: 1.246

3.  Bone resorption during the first year after implantation of a single-segment dynamic interspinous stabilization device and its risk factors.

Authors:  Kaifeng Wang; Zhenqi Zhu; Bo Wang; Yi Zhu; Haiying Liu
Journal:  BMC Musculoskelet Disord       Date:  2015-05-14       Impact factor: 2.362

Review 4.  Could the Topping-Off Technique Be the Preventive Strategy against Adjacent Segment Disease after Pedicle Screw-Based Fusion in Lumbar Degenerative Diseases? A Systematic Review.

Authors:  Po-Hsin Chou; Hsi-Hsien Lin; Howard S An; Kang-Ying Liu; Wei-Ren Su; Cheng-Li Lin
Journal:  Biomed Res Int       Date:  2017-02-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.